Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
6,959
+1,126
+19% +$204K 0.15% 79
2026
Q1
$858K Buy
5,833
+3,424
+142% +$557K 0.16% 76
2025
Q4
$470K Buy
2,409
+51
+2% +$12.1K 0.09% 101
2025
Q3
$663K Buy
2,358
+57
+2% +$14.5K 0.14% 79
2025
Q2
$503K Buy
2,301
+145
+7% +$23.4K 0.12% 97
2025
Q1
$301K Buy
2,156
+27
+1% +$4.4K 0.08% 120
2024
Q4
$355K Buy
2,129
+23
+1% +$4.09K 0.1% 107
2024
Q3
$359K Buy
2,106
+40
+2% +$5.79K 0.11% 111
2024
Q2
$292K Buy
2,066
+4
+0.2% +$497 0.09% 116
2024
Q1
$259K Buy
2,062
+75
+4% +$8.58K 0.09% 130
2023
Q4
$209K Sell
1,987
-313
-14% -$34.2K 0.08% 136
2023
Q3
$244K Buy
2,300
+200
+10% +$23.1K 0.11% 116
2023
Q2
$250K Buy
+2,100
New +$217K 0.23% 81

Other funds holding ORCL

Verum Partners's ORCL Position: Q2 2026 in Review

Verum Partners increased its Oracle (ORCL) stake by 19% in Q2 2026, buying an estimated $204K and bringing the position to 6,959 shares worth $1.02M. The position accounts for 0.15% of the portfolio, ranked #79.

Verum Partners first reported a position in ORCL in Q2 2023 and has held it in 13 quarters since. 912 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Verum Partners held 6,959 shares of Oracle worth $1.02M as of Q2 2026.
  • Verum Partners bought 1,126 Oracle shares in Q2 2026, an estimated $204K.
  • Oracle made up 0.15% of Verum Partners's portfolio in Q2 2026, its #79 holding.
  • Verum Partners first reported a position in Oracle in Q2 2023 and has held it in 13 quarters since.
  • 912 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.